Open AccessP450: PRECLINICAL AND CLINICAL SIGNS OF RVU120 EFFICACY, A SPECIFIC CDK8/19 INHIBITOR IN DNMT3A MUTATION POSITIVE AML AND HR‐MDS
Author(s) -
Pakulska U.,
Angelosanto N.,
Mikula M.,
Nogai H.,
Dudziak R.,
Abboud C.,
Obacz M.,
Goller K.,
Cybulska M.,
Mazan M.,
Kozakowska M.,
Rzymski T.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000844688.25652.68
Subject(s) - cancer research , pharmacology , biology , medicine , oncology